IPM vs IVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 16, 2026

IPM

55.4
AI Score
VS
IPM Wins

IVF

48.6
AI Score

Investment Advisor Scores

IPM

55score
Recommendation
HOLD

IVF

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IPM IVF Winner
Revenue 542,981 1.64M IVF
Net Income -934,151 -17.40M IPM
Net Margin -172.0% -1063.0% IPM
Operating Income -2.06M -1.20M IVF
ROE -5.0% -548.6% IPM
ROA -4.2% -54.8% IPM
Total Assets 22.47M 31.74M IVF
Cash 12.80M 840,407 IPM
Current Ratio 4.43 0.08 IPM

Relative Price Performance (Last 90 Days)

IPM 1M: +7.0% · 3M: -3.2% IVF 1M: -39.8% · 3M: -48.7%

Current Technical Phase

IPM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.7 · Price: $1.84

IVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.2%), weak momentum, RSI 38

RSI (14): 38.0 · Price: $0.98

Fundamentals Snapshot

Metric IPM IVF
Market Cap
Forward P/E 13.9 -0.1
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.2% 0.2%
Gross Margin 0.5% 0.4%
Operating Margin -0.1% -0.8%
EPS -0.26 254.30
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IPM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.